Search Results 81-90 of 318 for ❣베스트토토안전확인【평생베스트.com】베스트토토검증완료❣

  1. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

    This pilot phase I trial studies the side effects and best way to give sirolimus, gemcitabine hydrochloride, and cisplatin in treating patients at high risk ...

  2. A Study to Evaluate Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - Mayo Clinic

    About this study. The purpose of this study is to determine if patiromer treatment of subjects who developed hyperkalemia while receiving RAASi medications ...

  3. Testosterone (intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  4. Prenatal tests for genetic conditions are optional. It's important to make an informed decision about testing. That's especially important if you get tested ...

  5. Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. Gaming and Esports Medicine - Overview - Mayo Clinic

    Players' health is our top priority. Our GEM team is dedicated to promoting the health of esports players while establishing best practices for the gaming and ...

  7. https://www.mayoclinic.org/procedure_concepts.xml

  8. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

    ... best. Study phase. 1. During the early phases ... Females with false positive results and documented verification that the patient is not pregnant are eligible ...

  9. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

    This is an open label, multi-center, Phase Ib dose escalation study of BBI608 administered in combination with either FOLFOX6 with and without bevacizumab, or ...

  10. A Study of Disease Prediction for NOTCH3 - Mayo Clinic

    ... best. Study IDs. Site IRB. Jacksonville, Florida: 24-013764. About this study. The purpose of this study is to assess NOTCH3-SVD disease progression and develop ...